1-甲基靛红 | 2058-74-4

• 物质功能分类: 分析化学 - 标准品 - 药典标准品和杂质标准品
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1-甲基靛红
• 中文别名: 1-甲基吲哚-2,3-二酮；N-甲基靛红；N-甲基靛紅；1-甲基-2,3-吲哚二酮
• 英文名称: 1-methyl-1H-indole-2,3-dione
• 英文别名: N-methylisatin；1-methylindoline-2,3-dione；1-methylisatin；1-methylindole-2,3-dione
• CAS: 2058-74-4
• 化学式: C₉H₇NO₂
• mdl: MFCD00005812
• 分子量: 161.16
• InChiKey: VCYBVWFTGAZHGH-UHFFFAOYSA-N

物化性质

• 熔点：
  130-133 °C (lit.)
• 沸点：
  287.44°C (rough estimate)
• 密度：
  1.314
• 最大波长(λmax)：
  427nm(CH2Cl2)(lit.)
• 保留指数：
  1477
• 稳定性/保质期：

  如果遵照规格使用和储存，则不会分解，也未有已知危险反应。应避免与氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  37.4
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  T
• 危险类别码：
  R25
• 危险品运输编号：
  UN 2811 6.1/PG 3
• WGK Germany：
  3
• RTECS号：
  NL7939000
• 海关编码：
  2933990090
• 安全说明：
  S26,S39,S45
• 危险标志：
  GHS05,GHS06
• 危险性描述：
  H301,H315,H318,H335
• 危险性防范说明：
  P261,P280,P301 + P310,P305 + P351 + P338
• 储存条件：
  请将贮藏器保持密封，并存放在阴凉、干燥处。同时，确保工作环境具备良好的通风或排气设施。

SDS

Name:	1-Methylisatin 98% Material Safety Data Sheet
Synonym:
CAS:	2058-74-4

Section 1 - Chemical Product MSDS Name:1-Methylisatin 98% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
2058-74-4	1-Methylisatin	98%	218-164-9

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 2058-74-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: orange to brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 129-133 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H7NO2
Molecular Weight: 161.16

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 2058-74-4: NL7939000 LD50/LC50:
Not available.
Carcinogenicity:
1-Methylisatin - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 2058-74-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 2058-74-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2058-74-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

1-甲基靛青霉素是一种强效且选择性的羧酸酯酶（CE）抑制剂，其对hiCE和hCE1的Ki值分别为38.2 µM 和5.38 µM。该化合物通过疏水结合和静电吸引与成人血红蛋白（Hb）相互作用。因此，1-甲基靛青霉素可用于体内药物代谢调控的研究[1][2]。

反应信息

• 作为反应物：
  描述：

  1-甲基靛红 在 4-甲基苯磺酸吡啶 、 四氯化钛 、 锌 作用下， 以 四氢呋喃 、 苯 为溶剂， 反应 2.25h， 生成 1-methyl-3-(propan-2-ylidene)indoline-2-one
  参考文献：
  名称：

  低价钛对靛红与酮和醛的还原偶联

  摘要：

  Zn-TiCl 4在THF中将靛红与酮和醛还原偶联，可通过控制反应条件选择性地产生两电子还原产物和3-电子还原产物3-羟基-3-（1-羟基烷基）-吲哚和3-烷基亚乙基吲哚。尽管在某些情况下3-（1-羟烷基）恶吲哚也作为四电子还原产物产生，但这些产物容易脱水成3-亚烷基氧杂吲哚。衍生自醛的3-亚烷基氧杂吲哚形成为几何异构体的混合物。通过在催化剂中回流，将两种几何异构体异构化成平衡混合物。PPTS /苯。

  DOI：

  10.1016/j.tet.2014.10.071
• 作为产物：
  描述：

  2-氯-N-甲基-2-氧代-N-苯基乙酰胺 生成 1-甲基靛红
  参考文献：
  名称：

  Stolle et al., Journal fur praktische Chemie (Leipzig 1954), 1930, vol. <2>128, p. 1,23

  摘要：

  DOI：
• 作为试剂：
  描述：

  肌氨酸 、 对甲苯异硫氰酸酯 在 1-甲基靛红 作用下， 以 水 为溶剂， 生成 3-(4-methylphenyl)-1-methyl-2-thiohydantoin
  参考文献：
  名称：

  “水上”合成硫代咪唑啉酮-靛红/茚三酮缀合物，然后通过 ZnMnO3@Ni(OH)2 纳米催化剂进行温度诱导脱水

  摘要：

  一种新型高效的“水上”介导的一锅法ZnMnO 3 @Ni(OH) 2催化直接合成3-羟基-3-(3-甲基-5-氧代-2-硫代咪唑烷-4-基)羟吲哚已经探索了通过噻唑烷二酮-靛红缀合物。同时，还证明了3-羟基-3-(3-甲基-5-氧代-2-硫代咪唑啉-4-基)羟吲哚的温度调节脱水加合物。在水介质中使用可回收的ZnMnO 3 @Ni(OH) 2纳米催化剂使该方案具有可持续性和绿色性。使用粉末 XRD、HRTEM、EDX 和 BET 分析对 ZnMnO 3 @Ni(OH) 2纳米粉末的合成进行了细致的表征。此外，在温和且操作简单的反应条件下选择易于获得且易于制备的起始材料是该策略的主要优点。该催化剂具有高水相容性，并具有至少八个循环的回收和再利用能力。通过标准的浸出实验，证实该反应在这种可回收催化剂的作用下进行非均相。

  DOI：

  10.1039/d3gc03730d

文献信息

• Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani
  作者：Leena Gupta、Naresh Sunduru、Aditya Verma、Saumya Srivastava、Suman Gupta、Neena Goyal、Prem M.S. Chauhan

  DOI：10.1016/j.ejmech.2010.02.015

  日期：2010.6

  series of [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines were synthesized and screened for their in vitro antileishmanial activity against Leishmania donovani. Among all, 8 compounds have shown more than 90% inhibition against promastigotes and IC50 in the range of 4.01–57.78 μM against amastigotes. Compound 5, a triazino[5,6-b]indol-3-ylthio-1

  一系列的[1,2,4] triazino [5,6 - b ] indol-3-ylthio-1,3,5-triazines和[1,2,4] triazino [5,6 - b ] indol-3合成了-ylthiothiopyrimidines，并筛选了它们对利什曼原虫的体外抗疟原虫活性。在所有化合物中，有8种化合物对前鞭毛体的抑制作用超过90％，对Amastigotes的IC 50抑制作用在4.01至57.78μM之间。化合物5，一个嗪[5,6- b ]吲哚-3-基硫基-1,3,5-三嗪衍生物被发现是最活跃的，并用20-＆毒性最低的10倍的选择性（SI = 56.61）与标准药物喷他idine和stibogluconate（SSG）相比。
• Synthesis, Anticancer and Antibacterial Activity of Some Novel Mononuclear Ru(II) Complexes
  作者：Upal Kanti Mazumder、Malaya Gupta、Subhas Somalingappa Karki、Shiladitya Bhattacharya、Suresh Rathinasamy、Sivakumar Thangavel

  DOI：10.1248/cpb.52.178

  日期：——

  In search of potential anticancer drug candidates in ruthenium complexes, a series of mononuclear ruthenium complexes of the type [Ru(phen)2(nmit)]Cl2 (Ru1), [Ru(bpy)2(nmit)]Cl2 (Ru2), [Ru(phen)2(icpl)]Cl2 (Ru3), Ru(bpy)2(icpl)]Cl2 (Ru4) (phen=1,10-phenanthroline; bpy=2,2′-bipyridine; nmit=N-methyl-isatin-3-thiosemicarbazone, icpl=isatin-3-(4-Cl-phenyl)thiosemicarbazone) and [Ru(phen)2(aze)]Cl2 (Ru5), [Ru(bpy)2(aze)]Cl2 (Ru6) (aze=acetazolamide) and [Ru(phen)2(R-tsc)](ClO4)2 (R=methyl (Ru7), ethyl (Ru8), cyclohexyl (Ru9), 4-Cl-phenyl (10), 4-Br-phenyl (Ru11), and 4-EtO-phenyl (Ru12), tsc=thiosemicarbazone) were prepared and characterized by elemental analysis, FTIR, 1H-NMR and FAB-MS. Effect of these complexes on the growth of a transplantable murine tumor cell line (Ehrlich Ascites Carcinoma) and their antibacterial activity were studied. In cancer study the effect of hematological profile of the tumor hosts have also been studied. In the cancer study, the complexes Ru1—Ru4, Ru10 and Ru11 have remarkably decreased the tumor volume and viable ascitic cell count as indicated by trypan blue dye exclusion test (p<0.05). Treatment with the ruthenium complexes prolonged the lifespan of Ehrlich Ascites Carcinoma (EAC) bearing mice. Tumor inhibition by the ruthenium chelates was followed by improvements in hemoglobin, RBC and WBC values. All the complexes showed antibacterial activity, except Ru5 and Ru6. Thus, the results suggest that these ruthenium complexes have significant antitumor property and antibacterial activity. The results also reflect that the drug does not adversely affect the hematological profiles as compared to that of cisplatin on the host.

  为了寻找潜在的抗癌药物候选物，合成并表征了一系列单核钌配合物，包括[Ru(phen)2(nmit)]Cl2 (Ru1)、[Ru(bpy)2(nmit)]Cl2 (Ru2)、[Ru(phen)2(icpl)]Cl2 (Ru3)、[Ru(bpy)2(icpl)]Cl2 (Ru4)（其中phen=1,10-菲咯啉，bpy=2,2'-联吡啶，nmit=N-甲基-异氮茚-3-缩氨基硫脲，icpl=异氮茚-3-(4-氯苯基)缩氨基硫脲），以及[Ru(phen)2(aze)]Cl2 (Ru5)、[Ru(bpy)2(aze)]Cl2 (Ru6)（aze=醋唑磺胺）和[Ru(phen)2(R-tsc)](ClO4)2（R=甲基(Ru7)、乙基(Ru8)、环己基(Ru9)、4-氯苯基(Ru10)、4-溴苯基(Ru11)和4-乙氧基苯基(Ru12)，tsc=缩氨基硫脲）。研究了这些配合物对可移植的小鼠肿瘤细胞系（埃利希腹水癌）生长的影响及其抗菌活性。在癌症研究中，还研究了肿瘤宿主血液学特征的影响。在癌症研究中，配合物Ru1—Ru4、Ru10和Ru11显著减少了肿瘤体积和活腹水细胞数量，通过台阶蓝染色排斥试验显示（p<0.05）。使用这些钌配合物治疗延长了携带埃利希腹水癌（EAC）小鼠的寿命。钌配合物抑制肿瘤后，血红蛋白、红细胞和白细胞值有所改善。所有配合物都显示出抗菌活性，除了Ru5和Ru6。因此，结果表明这些钌配合物具有显著的抗肿瘤特性和抗菌活性。结果还反映出，与顺铂相比，该药物对宿主的血液学特征没有负面影响。
• Access to Spirocyclized Oxindoles and Indolenines via Palladium-Catalyzed Cascade Reactions of Propargyl Carbonates with 2-Oxotryptamines and Tryptamines
  作者：Antoinette E. Nibbs、Thomas D. Montgomery、Ye Zhu、Viresh H. Rawal

  DOI：10.1021/acs.joc.5b00277

  日期：2015.5.15

  through a process wherein the first nucleophilic unit on the oxindole or indole reacts with an allenyl-palladium species, formed from oxidative addition of Pd(0) to propargyl carbonates, to generate a π-allyl palladium intermediate that then reacts further with the second nucleophilic component of the oxindole or indole. The cascade process forges two bonds en route to spirocyclized oxindole and indolenine

  这里报道的是直接构建一系列螺环化的吲哚和吲哚类化合物的方法，它们的产率都很高到极好。具体来说，我们报告了钯和双炔碳酸酯，它们均作为双亲核试剂与羟吲哚和吲哚发生钯催化反应，以提供在新形成的环上具有环外双键的螺环产物。反应通过一个过程进行，在该过程中，羟吲哚或吲哚上的第一个亲核单元与通过将Pd（0）氧化加成炔丙基碳酸酯而形成的烯丙基-钯物质反应，生成π-烯丙基钯中间体，然后该中间体进一步与羟吲哚或吲哚的第二个亲核组分。级联过程在螺环化的吲哚和吲哚烯产品中形成了两个键。
• Site-Selective C–H Functionalization of (Hetero)Arenes via Transient, Non-symmetric Iodanes
  作者：Stacy C. Fosu、Chido M. Hambira、Andrew D. Chen、James R. Fuchs、David A. Nagib

  DOI：10.1016/j.chempr.2018.11.007

  日期：2019.2

  A strategy for C–H functionalization of arenes and heteroarenes has been developed to allow site-selective incorporation of various anions, including Cl, Br, OMs, OTs, and OTf. This approach is enabled by in situ generation of reactive, non-symmetric iodanes by combining anions and bench-stable PhI(OAc)2. The utility of this mechanism is demonstrated via para-selective chlorination of medicinally relevant

  已经开发了一种将芳烃和杂芳烃进行C-H官能化的策略，以允许位点选择性结合各种阴离子，包括Cl，Br，OMs，OTs和OTf。通过结合阴离子和稳定的PhI（OAc）2原位生成反应性，不对称碘化物，可以实现此方法。该机制的实用性通过与药用相关的芳烃的对位选择性氯化以及杂芳烃的位点选择性C–H氯化反应得以证明。光谱，计算和竞争实验描述了这些瞬态，不对称碘的独特性质，反应性和选择性。
• Autoxidation/Aldol Tandem Reaction of 2-Oxindoles with Ketones: A Green Approach for the Synthesis of 3-Hydroxy-2-Oxindoles
  作者：Qing-Bao Zhang、Wen-Liang Jia、Yong-Liang Ban、Yong Zheng、Qiang Liu、Li-Zhu Wu

  DOI：10.1002/chem.201504282

  日期：2016.2.18

  In the presence of tetrabutylammonium fluoride and molecular sieves (MS) 4 Å in DMF, an efficient autoxidation reaction of 2‐oxindoles with ketones under air at room temperature has been developed. This approach may provide a green, practical, and metal‐free protocol for a wide range of biologically important 3‐hydroxy‐3‐(2‐oxo‐alkyl)‐2‐oxindoles.

  在DMF中存在四丁基氟化铵和分子筛（MS）4Å的情况下，已开发出室温下空气中2-氧吲哚与酮的有效自氧化反应。这种方法可能为多种生物学上重要的3-羟基-3-（2-氧代烷基）-2-氧吲哚提供绿色，实用且不含金属的方案。

表征谱图